Concepts (361)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthroplasty, Replacement, Knee | 73 | 2023 | 688 | 14.760 |
Why?
|
Arthroplasty, Replacement, Hip | 48 | 2023 | 860 | 10.000 |
Why?
|
Knee Prosthesis | 28 | 2023 | 240 | 8.630 |
Why?
|
Knee Joint | 42 | 2022 | 826 | 6.230 |
Why?
|
Hip Prosthesis | 26 | 2023 | 578 | 6.180 |
Why?
|
Femur | 20 | 2020 | 402 | 4.670 |
Why?
|
Surgery, Computer-Assisted | 16 | 2017 | 62 | 4.570 |
Why?
|
Prosthesis Failure | 24 | 2023 | 539 | 3.590 |
Why?
|
Prosthesis Design | 28 | 2023 | 507 | 3.280 |
Why?
|
Osteoarthritis, Knee | 20 | 2019 | 400 | 3.210 |
Why?
|
Tibia | 17 | 2019 | 274 | 3.080 |
Why?
|
Hip Joint | 17 | 2017 | 406 | 3.060 |
Why?
|
Middle Aged | 80 | 2021 | 10195 | 2.770 |
Why?
|
Retrospective Studies | 55 | 2022 | 3658 | 2.630 |
Why?
|
Bone Cements | 7 | 2023 | 95 | 2.600 |
Why?
|
Reoperation | 25 | 2023 | 950 | 2.580 |
Why?
|
Aged | 70 | 2021 | 10048 | 2.410 |
Why?
|
Humans | 123 | 2023 | 30997 | 2.360 |
Why?
|
Postoperative Period | 22 | 2020 | 302 | 2.270 |
Why?
|
Female | 82 | 2022 | 16983 | 2.140 |
Why?
|
Male | 81 | 2022 | 16445 | 2.140 |
Why?
|
Pain, Postoperative | 11 | 2020 | 334 | 2.000 |
Why?
|
Postoperative Complications | 15 | 2022 | 991 | 1.900 |
Why?
|
Osteoarthritis, Hip | 5 | 2018 | 95 | 1.790 |
Why?
|
Patient Satisfaction | 8 | 2019 | 310 | 1.760 |
Why?
|
Metal-on-Metal Joint Prostheses | 5 | 2017 | 54 | 1.710 |
Why?
|
Tomography, X-Ray Computed | 8 | 2017 | 817 | 1.700 |
Why?
|
Acetabulum | 6 | 2016 | 203 | 1.600 |
Why?
|
Prospective Studies | 21 | 2020 | 1897 | 1.600 |
Why?
|
Bone Malalignment | 7 | 2014 | 20 | 1.550 |
Why?
|
Treatment Outcome | 31 | 2023 | 3806 | 1.540 |
Why?
|
Anticoagulants | 4 | 2015 | 108 | 1.470 |
Why?
|
Adult | 38 | 2019 | 8931 | 1.470 |
Why?
|
Venous Thromboembolism | 3 | 2015 | 40 | 1.440 |
Why?
|
Joint Diseases | 4 | 2016 | 114 | 1.390 |
Why?
|
Radiography | 20 | 2017 | 695 | 1.330 |
Why?
|
Range of Motion, Articular | 15 | 2017 | 736 | 1.320 |
Why?
|
Recovery of Function | 11 | 2016 | 298 | 1.240 |
Why?
|
Magnetic Resonance Imaging | 9 | 2017 | 1311 | 1.230 |
Why?
|
Noise | 3 | 2017 | 24 | 1.230 |
Why?
|
Warfarin | 4 | 2015 | 38 | 1.200 |
Why?
|
Bone Density | 3 | 2018 | 152 | 1.160 |
Why?
|
Imaging, Three-Dimensional | 9 | 2016 | 230 | 1.140 |
Why?
|
Chromium | 3 | 2016 | 93 | 1.120 |
Why?
|
Cobalt | 3 | 2016 | 113 | 1.100 |
Why?
|
Metals | 4 | 2017 | 154 | 1.080 |
Why?
|
Prosthesis-Related Infections | 5 | 2020 | 222 | 1.050 |
Why?
|
Aspirin | 3 | 2015 | 87 | 1.040 |
Why?
|
Foreign-Body Reaction | 2 | 2017 | 28 | 1.040 |
Why?
|
Venous Thrombosis | 2 | 2015 | 45 | 0.940 |
Why?
|
Osteolysis | 2 | 2017 | 147 | 0.920 |
Why?
|
Titanium | 4 | 2020 | 196 | 0.880 |
Why?
|
Arthritis | 4 | 2020 | 105 | 0.850 |
Why?
|
Biomechanical Phenomena | 11 | 2017 | 698 | 0.840 |
Why?
|
Cholecalciferol | 1 | 2022 | 7 | 0.830 |
Why?
|
Hip Dislocation | 6 | 2023 | 68 | 0.820 |
Why?
|
Aged, 80 and over | 18 | 2019 | 5189 | 0.820 |
Why?
|
Synovial Fluid | 2 | 2020 | 127 | 0.820 |
Why?
|
Negative-Pressure Wound Therapy | 2 | 2021 | 4 | 0.810 |
Why?
|
Arthroplasty, Replacement | 4 | 2013 | 150 | 0.790 |
Why?
|
Age Factors | 9 | 2018 | 873 | 0.770 |
Why?
|
Accelerometry | 2 | 2012 | 94 | 0.770 |
Why?
|
Surgical Wound | 2 | 2018 | 12 | 0.760 |
Why?
|
Surveys and Questionnaires | 9 | 2019 | 1210 | 0.760 |
Why?
|
Surgical Wound Infection | 3 | 2021 | 103 | 0.730 |
Why?
|
Registries | 2 | 2018 | 203 | 0.710 |
Why?
|
Pain Measurement | 4 | 2016 | 489 | 0.700 |
Why?
|
Specimen Handling | 1 | 2020 | 52 | 0.690 |
Why?
|
Lower Extremity | 3 | 2015 | 40 | 0.690 |
Why?
|
Periprosthetic Fractures | 1 | 2020 | 32 | 0.680 |
Why?
|
Joint Dislocations | 3 | 2023 | 60 | 0.650 |
Why?
|
Computer-Aided Design | 2 | 2016 | 16 | 0.650 |
Why?
|
Equipment Failure Analysis | 4 | 2014 | 104 | 0.650 |
Why?
|
Incidence | 9 | 2018 | 785 | 0.640 |
Why?
|
Intermittent Pneumatic Compression Devices | 2 | 2015 | 7 | 0.610 |
Why?
|
Acceleration | 3 | 2012 | 20 | 0.610 |
Why?
|
Research Design | 3 | 2015 | 219 | 0.600 |
Why?
|
Ankle Joint | 5 | 2016 | 41 | 0.590 |
Why?
|
Genu Varum | 1 | 2017 | 3 | 0.570 |
Why?
|
Cadaver | 4 | 2012 | 380 | 0.570 |
Why?
|
Weight-Bearing | 2 | 2014 | 170 | 0.570 |
Why?
|
Risk Factors | 9 | 2022 | 2588 | 0.560 |
Why?
|
Severity of Illness Index | 6 | 2019 | 1133 | 0.550 |
Why?
|
Patient Reported Outcome Measures | 3 | 2019 | 434 | 0.550 |
Why?
|
Pelvic Bones | 1 | 2016 | 20 | 0.550 |
Why?
|
Risk Assessment | 3 | 2018 | 718 | 0.550 |
Why?
|
Femur Neck | 1 | 2016 | 18 | 0.540 |
Why?
|
Supine Position | 1 | 2016 | 17 | 0.530 |
Why?
|
Prosthesis Fitting | 2 | 2013 | 24 | 0.530 |
Why?
|
Analgesics, Opioid | 6 | 2020 | 226 | 0.520 |
Why?
|
Young Adult | 10 | 2019 | 2063 | 0.520 |
Why?
|
Posture | 4 | 2017 | 72 | 0.520 |
Why?
|
Patient Discharge | 3 | 2019 | 164 | 0.510 |
Why?
|
Hypersensitivity | 1 | 2016 | 47 | 0.510 |
Why?
|
Orthopedic Procedures | 1 | 2018 | 329 | 0.480 |
Why?
|
International Normalized Ratio | 1 | 2014 | 24 | 0.480 |
Why?
|
Osteoarthritis | 2 | 2016 | 384 | 0.450 |
Why?
|
Patella | 1 | 2014 | 88 | 0.440 |
Why?
|
Reproducibility of Results | 6 | 2019 | 818 | 0.440 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 90 | 0.440 |
Why?
|
Leg Length Inequality | 1 | 2013 | 12 | 0.430 |
Why?
|
Fibrosis | 1 | 2013 | 39 | 0.430 |
Why?
|
Patellofemoral Joint | 1 | 2014 | 61 | 0.420 |
Why?
|
Missouri | 4 | 2016 | 27 | 0.420 |
Why?
|
Computer Simulation | 2 | 2016 | 222 | 0.420 |
Why?
|
Stereotaxic Techniques | 1 | 2012 | 24 | 0.410 |
Why?
|
Time Factors | 8 | 2019 | 1672 | 0.400 |
Why?
|
Muscular Diseases | 1 | 2012 | 17 | 0.400 |
Why?
|
Anti-Bacterial Agents | 4 | 2018 | 420 | 0.380 |
Why?
|
Blood Transfusion | 4 | 2022 | 65 | 0.380 |
Why?
|
United States | 9 | 2018 | 2375 | 0.380 |
Why?
|
Viscosity | 4 | 2019 | 10 | 0.370 |
Why?
|
Rotation | 4 | 2014 | 142 | 0.370 |
Why?
|
Porosity | 2 | 2022 | 68 | 0.370 |
Why?
|
Lumbar Vertebrae | 1 | 2016 | 523 | 0.370 |
Why?
|
Pain | 4 | 2019 | 426 | 0.360 |
Why?
|
Osteoporosis | 1 | 2011 | 85 | 0.360 |
Why?
|
Joint Prosthesis | 4 | 2019 | 79 | 0.340 |
Why?
|
Adolescent | 6 | 2019 | 2401 | 0.340 |
Why?
|
Patient Positioning | 4 | 2017 | 41 | 0.340 |
Why?
|
Follow-Up Studies | 7 | 2021 | 1922 | 0.330 |
Why?
|
Cartilage, Articular | 1 | 2014 | 550 | 0.330 |
Why?
|
Rotator Cuff | 1 | 2012 | 283 | 0.330 |
Why?
|
Spinal Fusion | 1 | 2016 | 562 | 0.320 |
Why?
|
Length of Stay | 5 | 2019 | 339 | 0.320 |
Why?
|
Body Mass Index | 4 | 2020 | 452 | 0.310 |
Why?
|
Femur Head | 4 | 2023 | 67 | 0.300 |
Why?
|
Enterocolitis, Pseudomembranous | 2 | 2018 | 16 | 0.300 |
Why?
|
Arthroscopy | 2 | 2014 | 892 | 0.300 |
Why?
|
Joint Instability | 4 | 2019 | 405 | 0.290 |
Why?
|
Chi-Square Distribution | 3 | 2016 | 147 | 0.290 |
Why?
|
Arthritis, Rheumatoid | 3 | 2019 | 365 | 0.280 |
Why?
|
Absorptiometry, Photon | 2 | 2018 | 83 | 0.280 |
Why?
|
Corrosion | 3 | 2017 | 133 | 0.280 |
Why?
|
Arthroplasty, Replacement, Elbow | 2 | 2019 | 7 | 0.280 |
Why?
|
Osteocytes | 2 | 2019 | 15 | 0.280 |
Why?
|
Polyethylene | 4 | 2019 | 121 | 0.280 |
Why?
|
Blood Loss, Surgical | 2 | 2020 | 67 | 0.270 |
Why?
|
Hip Fractures | 2 | 2018 | 34 | 0.270 |
Why?
|
Pain Management | 4 | 2020 | 144 | 0.260 |
Why?
|
Patient Readmission | 3 | 2018 | 132 | 0.260 |
Why?
|
Sex Factors | 3 | 2017 | 511 | 0.260 |
Why?
|
Elbow Joint | 2 | 2019 | 132 | 0.250 |
Why?
|
Hemorrhage | 2 | 2015 | 79 | 0.250 |
Why?
|
Hand | 2 | 2018 | 45 | 0.250 |
Why?
|
Awards and Prizes | 2 | 2016 | 24 | 0.240 |
Why?
|
Cytokines | 2 | 2019 | 351 | 0.240 |
Why?
|
Stress, Mechanical | 3 | 2014 | 173 | 0.230 |
Why?
|
Comorbidity | 2 | 2022 | 508 | 0.220 |
Why?
|
Therapeutic Irrigation | 2 | 2020 | 71 | 0.220 |
Why?
|
Cohort Studies | 4 | 2020 | 2043 | 0.220 |
Why?
|
Double-Blind Method | 2 | 2022 | 499 | 0.210 |
Why?
|
Gait | 2 | 2017 | 407 | 0.210 |
Why?
|
Urinary Retention | 1 | 2022 | 12 | 0.210 |
Why?
|
Time and Motion Studies | 1 | 2022 | 18 | 0.210 |
Why?
|
Urinary Tract Infections | 1 | 2022 | 34 | 0.210 |
Why?
|
Patient Selection | 2 | 2014 | 246 | 0.200 |
Why?
|
Dietary Supplements | 1 | 2022 | 63 | 0.200 |
Why?
|
Opioid-Related Disorders | 2 | 2020 | 48 | 0.200 |
Why?
|
Vitamin D | 1 | 2022 | 42 | 0.200 |
Why?
|
Algorithms | 3 | 2019 | 414 | 0.200 |
Why?
|
Cementation | 1 | 2021 | 33 | 0.190 |
Why?
|
Equipment Design | 2 | 2012 | 181 | 0.190 |
Why?
|
Postural Balance | 1 | 2022 | 124 | 0.190 |
Why?
|
Surface Properties | 2 | 2019 | 133 | 0.180 |
Why?
|
Orthopedics | 2 | 2013 | 128 | 0.180 |
Why?
|
Refuse Disposal | 1 | 2020 | 2 | 0.180 |
Why?
|
Antifibrinolytic Agents | 1 | 2020 | 21 | 0.180 |
Why?
|
Tranexamic Acid | 1 | 2020 | 21 | 0.180 |
Why?
|
Leukocyte Count | 1 | 2020 | 93 | 0.180 |
Why?
|
Acetaminophen | 1 | 2020 | 21 | 0.170 |
Why?
|
Prescriptions | 1 | 2020 | 18 | 0.170 |
Why?
|
Los Angeles | 2 | 2017 | 7 | 0.170 |
Why?
|
Arthroplasty | 2 | 2018 | 141 | 0.170 |
Why?
|
Osteoclasts | 1 | 2019 | 22 | 0.170 |
Why?
|
Tertiary Care Centers | 1 | 2020 | 74 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 190 | 0.170 |
Why?
|
Neutrophils | 1 | 2020 | 120 | 0.170 |
Why?
|
Pain Perception | 1 | 2019 | 6 | 0.170 |
Why?
|
Cell Differentiation | 1 | 2019 | 152 | 0.160 |
Why?
|
Pelvis | 2 | 2016 | 33 | 0.160 |
Why?
|
Oxycodone | 1 | 2019 | 5 | 0.160 |
Why?
|
Survivorship | 1 | 2019 | 19 | 0.160 |
Why?
|
Wound Healing | 2 | 2018 | 174 | 0.160 |
Why?
|
Mobile Applications | 1 | 2019 | 24 | 0.160 |
Why?
|
Patient Education as Topic | 1 | 2020 | 161 | 0.160 |
Why?
|
Drug Prescriptions | 1 | 2019 | 35 | 0.160 |
Why?
|
alpha-Defensins | 1 | 2018 | 3 | 0.160 |
Why?
|
Ceramics | 2 | 2015 | 25 | 0.160 |
Why?
|
Physical Therapy Modalities | 1 | 2019 | 78 | 0.160 |
Why?
|
Surgical Wound Dehiscence | 1 | 2018 | 10 | 0.160 |
Why?
|
Apoptosis | 1 | 2019 | 260 | 0.150 |
Why?
|
Logistic Models | 2 | 2016 | 409 | 0.150 |
Why?
|
Morphine | 1 | 2019 | 85 | 0.150 |
Why?
|
Surgeons | 2 | 2019 | 87 | 0.150 |
Why?
|
Bone Remodeling | 1 | 2018 | 46 | 0.150 |
Why?
|
Drainage | 1 | 2018 | 52 | 0.150 |
Why?
|
Databases, Factual | 2 | 2018 | 354 | 0.150 |
Why?
|
Practice Patterns, Physicians' | 1 | 2019 | 135 | 0.150 |
Why?
|
Preoperative Period | 2 | 2020 | 76 | 0.150 |
Why?
|
Knee | 1 | 2017 | 47 | 0.150 |
Why?
|
Arthritis, Infectious | 1 | 2018 | 63 | 0.140 |
Why?
|
Motion | 1 | 2016 | 23 | 0.140 |
Why?
|
Spine | 1 | 2018 | 132 | 0.140 |
Why?
|
Mupirocin | 1 | 2016 | 17 | 0.140 |
Why?
|
Fascia Lata | 1 | 2016 | 11 | 0.140 |
Why?
|
Sacrum | 1 | 2016 | 29 | 0.140 |
Why?
|
Ions | 1 | 2016 | 54 | 0.140 |
Why?
|
Thigh | 1 | 2016 | 32 | 0.140 |
Why?
|
Patient Outcome Assessment | 1 | 2016 | 44 | 0.130 |
Why?
|
Auditory Perception | 1 | 2016 | 36 | 0.130 |
Why?
|
Chlorhexidine | 1 | 2016 | 61 | 0.130 |
Why?
|
Stockings, Compression | 1 | 2015 | 2 | 0.130 |
Why?
|
Midwestern United States | 1 | 2016 | 71 | 0.130 |
Why?
|
Internal Fixators | 1 | 2016 | 53 | 0.130 |
Why?
|
Tennessee | 1 | 2015 | 9 | 0.130 |
Why?
|
Rats | 2 | 2019 | 873 | 0.130 |
Why?
|
Multivariate Analysis | 1 | 2016 | 341 | 0.130 |
Why?
|
Great Lakes Region | 1 | 2015 | 1 | 0.130 |
Why?
|
Preoperative Care | 2 | 2014 | 144 | 0.130 |
Why?
|
Vulnerable Populations | 1 | 2015 | 25 | 0.130 |
Why?
|
Joint Capsule | 2 | 2012 | 46 | 0.120 |
Why?
|
Pulmonary Embolism | 1 | 2015 | 64 | 0.120 |
Why?
|
Regional Health Planning | 1 | 2014 | 4 | 0.120 |
Why?
|
Alloys | 1 | 2015 | 94 | 0.120 |
Why?
|
Chemoprevention | 1 | 2014 | 5 | 0.120 |
Why?
|
Shoulder Joint | 2 | 2012 | 605 | 0.120 |
Why?
|
Patients | 1 | 2015 | 33 | 0.120 |
Why?
|
Drug Monitoring | 1 | 2014 | 25 | 0.120 |
Why?
|
Arthritis, Juvenile | 1 | 2014 | 8 | 0.120 |
Why?
|
Software | 1 | 2014 | 72 | 0.120 |
Why?
|
Perception | 1 | 2015 | 85 | 0.120 |
Why?
|
Disease Models, Animal | 2 | 2019 | 782 | 0.120 |
Why?
|
Knee Dislocation | 1 | 2014 | 7 | 0.120 |
Why?
|
Femoral Nerve | 1 | 2014 | 10 | 0.120 |
Why?
|
Sexual Behavior | 1 | 2014 | 61 | 0.120 |
Why?
|
Survival Rate | 1 | 2015 | 404 | 0.120 |
Why?
|
Amides | 1 | 2014 | 21 | 0.120 |
Why?
|
Hip Dislocation, Congenital | 1 | 2014 | 4 | 0.120 |
Why?
|
Obesity | 1 | 2017 | 307 | 0.120 |
Why?
|
Analgesia, Epidural | 1 | 2014 | 59 | 0.110 |
Why?
|
Patellar Ligament | 1 | 2014 | 56 | 0.110 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2014 | 225 | 0.110 |
Why?
|
Disability Evaluation | 1 | 2016 | 333 | 0.110 |
Why?
|
Fluoroscopy | 1 | 2013 | 62 | 0.110 |
Why?
|
Anesthetics, Local | 1 | 2014 | 97 | 0.110 |
Why?
|
Connective Tissue | 1 | 2013 | 26 | 0.110 |
Why?
|
Nerve Block | 1 | 2014 | 65 | 0.110 |
Why?
|
Pressure | 1 | 2013 | 63 | 0.110 |
Why?
|
Leg | 1 | 2013 | 51 | 0.110 |
Why?
|
Hip | 1 | 2013 | 44 | 0.100 |
Why?
|
Case-Control Studies | 1 | 2014 | 662 | 0.100 |
Why?
|
Femoral Neck Fractures | 1 | 2012 | 12 | 0.100 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 549 | 0.100 |
Why?
|
Foreign-Body Migration | 1 | 2012 | 22 | 0.100 |
Why?
|
Pregnancy | 1 | 2013 | 404 | 0.100 |
Why?
|
Confidence Intervals | 1 | 2012 | 96 | 0.100 |
Why?
|
Vasculitis | 1 | 2012 | 31 | 0.100 |
Why?
|
Chromium Alloys | 1 | 2012 | 48 | 0.100 |
Why?
|
Statistics as Topic | 1 | 2012 | 116 | 0.100 |
Why?
|
Hemiarthroplasty | 1 | 2012 | 31 | 0.100 |
Why?
|
Ultrasonography | 1 | 2014 | 271 | 0.100 |
Why?
|
Lymphocytes | 1 | 2012 | 111 | 0.100 |
Why?
|
Arthritis, Psoriatic | 1 | 2012 | 19 | 0.100 |
Why?
|
Intraoperative Period | 1 | 2011 | 33 | 0.100 |
Why?
|
Computers, Handheld | 1 | 2011 | 14 | 0.100 |
Why?
|
Rats, Sprague-Dawley | 1 | 2013 | 468 | 0.100 |
Why?
|
Patellar Dislocation | 1 | 2012 | 23 | 0.100 |
Why?
|
External Fixators | 1 | 2011 | 10 | 0.100 |
Why?
|
Quality of Life | 1 | 2017 | 696 | 0.100 |
Why?
|
Societies, Medical | 1 | 2013 | 191 | 0.100 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2011 | 41 | 0.100 |
Why?
|
Analysis of Variance | 1 | 2012 | 324 | 0.100 |
Why?
|
Exercise | 1 | 2016 | 507 | 0.100 |
Why?
|
Educational Measurement | 1 | 2011 | 61 | 0.090 |
Why?
|
Shoulder Injuries | 1 | 2012 | 143 | 0.090 |
Why?
|
Health Status | 1 | 2012 | 239 | 0.090 |
Why?
|
Arthralgia | 1 | 2012 | 133 | 0.090 |
Why?
|
Movement | 1 | 2011 | 137 | 0.090 |
Why?
|
Athletic Injuries | 1 | 2012 | 180 | 0.090 |
Why?
|
Signal Transduction | 1 | 2013 | 498 | 0.090 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 1009 | 0.090 |
Why?
|
Cost-Benefit Analysis | 3 | 2016 | 148 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 464 | 0.080 |
Why?
|
Coated Materials, Biocompatible | 1 | 2009 | 41 | 0.080 |
Why?
|
Animals | 2 | 2019 | 4723 | 0.080 |
Why?
|
Rotator Cuff Injuries | 1 | 2012 | 298 | 0.080 |
Why?
|
Internship and Residency | 1 | 2011 | 227 | 0.070 |
Why?
|
Risk | 2 | 2019 | 221 | 0.070 |
Why?
|
Elective Surgical Procedures | 2 | 2019 | 43 | 0.070 |
Why?
|
Early Ambulation | 2 | 2019 | 20 | 0.070 |
Why?
|
Odds Ratio | 2 | 2019 | 291 | 0.070 |
Why?
|
Medicare | 2 | 2015 | 127 | 0.060 |
Why?
|
Urinary Catheterization | 1 | 2022 | 7 | 0.050 |
Why?
|
Urinary Catheters | 1 | 2022 | 5 | 0.050 |
Why?
|
Catheters | 1 | 2022 | 17 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 583 | 0.050 |
Why?
|
Silver | 1 | 2021 | 4 | 0.050 |
Why?
|
Bandages | 1 | 2021 | 10 | 0.050 |
Why?
|
Cluster Analysis | 1 | 2020 | 53 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 225 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2020 | 120 | 0.040 |
Why?
|
Benzodiazepines | 1 | 2020 | 58 | 0.040 |
Why?
|
Bone-Implant Interface | 1 | 2019 | 7 | 0.040 |
Why?
|
Povidone-Iodine | 1 | 2019 | 7 | 0.040 |
Why?
|
Antidepressive Agents | 1 | 2020 | 100 | 0.040 |
Why?
|
X-Ray Microtomography | 1 | 2019 | 81 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 105 | 0.040 |
Why?
|
Bone Resorption | 1 | 2019 | 97 | 0.040 |
Why?
|
Demography | 1 | 2019 | 81 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2019 | 329 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2019 | 430 | 0.040 |
Why?
|
Body Weight | 1 | 2019 | 141 | 0.040 |
Why?
|
Regression Analysis | 1 | 2019 | 300 | 0.040 |
Why?
|
Analgesics | 1 | 2019 | 109 | 0.040 |
Why?
|
Colitis | 1 | 2017 | 41 | 0.040 |
Why?
|
Inpatients | 1 | 2019 | 150 | 0.040 |
Why?
|
Smoking | 1 | 2018 | 197 | 0.030 |
Why?
|
Administration, Intranasal | 1 | 2016 | 26 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2020 | 551 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2016 | 88 | 0.030 |
Why?
|
Hospital Costs | 1 | 2016 | 68 | 0.030 |
Why?
|
Quality Improvement | 1 | 2017 | 165 | 0.030 |
Why?
|
Robotic Surgical Procedures | 1 | 2016 | 24 | 0.030 |
Why?
|
Precision Medicine | 1 | 2015 | 29 | 0.030 |
Why?
|
Medicaid | 1 | 2015 | 39 | 0.030 |
Why?
|
Spain | 1 | 2014 | 12 | 0.030 |
Why?
|
Delphi Technique | 1 | 2014 | 30 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2015 | 57 | 0.030 |
Why?
|
Anatomic Landmarks | 1 | 2014 | 7 | 0.030 |
Why?
|
Zirconium | 1 | 2014 | 5 | 0.030 |
Why?
|
Biomarkers | 1 | 2018 | 733 | 0.030 |
Why?
|
Aluminum Oxide | 1 | 2014 | 7 | 0.030 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2014 | 22 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2015 | 132 | 0.030 |
Why?
|
Infusions, Parenteral | 1 | 2014 | 13 | 0.030 |
Why?
|
New York City | 1 | 2014 | 17 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2017 | 370 | 0.030 |
Why?
|
Observer Variation | 1 | 2014 | 118 | 0.030 |
Why?
|
Health Surveys | 1 | 2014 | 99 | 0.030 |
Why?
|
Health Care Costs | 1 | 2015 | 71 | 0.030 |
Why?
|
Staphylococcal Infections | 1 | 2016 | 185 | 0.030 |
Why?
|
Hospitals | 1 | 2015 | 165 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 335 | 0.030 |
Why?
|
Device Removal | 1 | 2014 | 91 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2014 | 104 | 0.030 |
Why?
|
Linear Models | 1 | 2014 | 273 | 0.030 |
Why?
|
Accidental Falls | 1 | 2014 | 114 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 191 | 0.030 |
Why?
|
Fingers | 1 | 2012 | 12 | 0.020 |
Why?
|
Dermatologic Agents | 1 | 2012 | 7 | 0.020 |
Why?
|
Recurrence | 1 | 2012 | 370 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2012 | 103 | 0.020 |
Why?
|
Antirheumatic Agents | 1 | 2012 | 93 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 234 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2012 | 271 | 0.020 |
Why?
|
Models, Biological | 1 | 2012 | 346 | 0.020 |
Why?
|
Probability | 1 | 2009 | 99 | 0.020 |
Why?
|
Polyethylenes | 1 | 2009 | 40 | 0.020 |
Why?
|
Materials Testing | 1 | 2009 | 134 | 0.020 |
Why?
|
Child | 1 | 2012 | 1430 | 0.020 |
Why?
|